Plus Therapeutics updates corporate presentation; no specific new data disclosed

PLUS THERAPEUTICS, INC.

Filed updated investor presentation under Item 8.01.
Presentation slides filed as Exhibit 99.1, but no material changes evident from filing text.
No financial results, guidance, or operational milestones mentioned.

item 8.01 item 9.01

PLUS THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-018675

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.